Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. - Wikidata - wikimedia - TriplyDB

Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells.

Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells.

http://www.wikidata.org/entity/Q35191054

about

Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes Regional differences in cellular mechanisms of adipose tissue gain with overfeeding Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical Implications Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues Adipose tissue as a potential source of hematopoietic stem/progenitor cells The role of the myofibroblast in tumor stroma remodeling Mechanisms and metabolic implications of regional differences among fat depots The origin and definition of brite versus white and classical brown adipocytes The role for adipose tissue in weight regain after weight loss Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment Adipose-derived stem cells for regenerative medicine Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma Cre Recombinase Strains Used for the Study of Adipose Tissues and Adipocyte Progenitors.Adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low-magnitude mechanical signals Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells--a potential novel treatment for intervertebral disc degeneration.The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow.Utility of transplantation in studying adipocyte biogenesis and function Kinetic assessment and therapeutic modulation of metabolic and inflammatory profiles in mice on a high-fat and cholesterol diet Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.Fighting fat with fat: the expanding field of adipose stem cells.Characterization of stem and progenitor cells in the dental pulp of erupted and unerupted murine molars.Aging, depot origin, and preadipocyte gene expression.Analysis and isolation of adipocytes by flow cytometry.De novo generation of white adipocytes from the myeloid lineage via mesenchymal intermediates is age, adipose depot, and gender specific.Fat tissue, aging, and cellular senescence.Adipose lineage specification of bone marrow-derived myeloid cells.Independent stem cell lineages regulate adipose organogenesis and adipose homeostasis Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells Body mass index affects proliferation and osteogenic differentiation of human subcutaneous adipose tissue-derived stem cells Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation.Influence of BMI on level of circulating progenitor cells Formation and activation of thermogenic fat.Adipose tissue plasticity from WAT to BAT and in between.Adipose progenitor cells reside among the mature adipocytes: morphological research using an organotypic culture system.Diet-induced obesity in stem cell antigen-1 KO mice.

P2860

Q24623235-3F06534B-977C-451D-A766-1F7FC81B5082 Q24624643-EC227518-96D1-4791-921A-6CB28FAAF12E Q26742184-FDB2EC15-914B-4F3F-BE67-63B341526D24 Q26745520-8B59B843-D0E5-4BB5-953D-19374BF12796 Q26753066-6DD58265-F501-43F4-9132-7B9A448F0EAE Q26991965-D27A318B-5785-4A98-9035-B512FE5F40EA Q26997815-4A53D2B2-E24A-4FB2-A236-CCD269CFA7CB Q27004113-61B9F5FC-2104-4A20-AB2A-2E232F11E87F Q27013733-F3F1007A-B96F-4686-8B71-5088B43DE174 Q28080505-3C299338-B932-442F-A5F9-BB82F4DA8DD8 Q28080529-4788E0BF-0B34-4749-92F1-D2073EA4BD76 Q28301763-7BD2E7F4-5D4D-478F-A9D4-2E312F8AFA24 Q28307782-FD89788C-F89D-4282-A5C2-C2969915EFFF Q28505209-B9D0E956-6069-4C4C-A532-790748D12A90 Q30241907-0C65B014-5EA0-4FBA-955C-5BA7B94A6A1E Q30365397-47F6E2B5-9312-444C-AF39-9036D018DDED Q30409893-A923CFA8-75DE-4DCB-B35C-BBF1D1DB8484 Q33351534-24374783-2942-4A3A-B832-F616492069D2 Q33422940-C1776D8B-4C00-418D-A4F5-FCE945322171 Q33575086-8C8CED98-C648-43D8-98B0-B2F28F4CE017 Q33678794-47BE6FE4-F8BD-4384-B2C9-05C1D6BD757E Q33809501-8A24E432-D712-4259-B989-04360134D7E4 Q33863173-F2C4D257-5F0B-4653-B507-7F786630D04F Q33875822-99A707C4-51EC-47C5-9AAD-BC9A3075A026 Q33897511-5A40C3A5-C0B3-4DF5-980B-74C1D7FF469B Q33997296-B7BC4611-FAD2-43B7-BE81-74E1D9B3E1C1 Q34083370-2C6ADA40-643C-4FBF-8830-967C2F73BC77 Q34093108-211270CF-02E7-453B-B7B6-5246B640BBA1 Q34130783-D8DE7AB6-A8DD-42A0-8BC0-461DE24C134E Q34346254-2550E801-9EAF-4DED-BDBB-C16646F1CF0D Q34605960-2B77EC89-9677-48C9-A5A5-01B688993ADF Q34686863-65D57F62-1A07-41D8-8F41-91B545A5E71A Q34908624-E4120F45-1BE5-49C5-A5F9-6AF5705BBB2B Q35000376-9907BC88-CD96-4BBE-BA5E-5E6379B39CF0 Q35036928-1FE140A8-FDDA-435B-8225-8B524D0982FD Q35127782-37A0439E-7BBD-4873-A7EE-D0F84AD86BD3 Q35561446-FA578206-081F-4837-98A5-CBA06B095902 Q35619414-96AF316E-282B-4E0B-9E22-C5792B3FB09F Q35669821-981A1AB6-1AA1-414C-A8DC-E28F132AD3CB Q35673110-D79303B2-8181-4B89-9EE8-C53287560894

P2860

Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells.

http://www.wikidata.org/entity/Q35191054

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Rosiglitazone promotes develop ...... circulating progenitor cells.

@ast

Rosiglitazone promotes develop ...... circulating progenitor cells.

@en

type

label

Rosiglitazone promotes develop ...... circulating progenitor cells.

@ast

Rosiglitazone promotes develop ...... circulating progenitor cells.

@en

prefLabel

Rosiglitazone promotes develop ...... circulating progenitor cells.

@ast

Rosiglitazone promotes develop ...... circulating progenitor cells.

@en

P1433

Q35191054-D80C2582-2B1C-439C-B90A-3D8EE909C0E0

P1476

Q35191054-4B836455-37CA-443A-A71A-A7D9C02E15F0

P2093

Q35191054-10684613-6E49-49CC-8AD7-34D00E671DFD

Q35191054-3C0DB724-0C18-46B7-A959-61284BADFF6C

Q35191054-4E27DB9D-D70F-44A4-B28F-51E3A7F6E6BF

Q35191054-91C63B32-63AB-49C8-AFF4-5A54D636E5ED

Q35191054-9F842E95-8065-4EC0-9B26-C1FB066AEDD7

P2860

Q35191054-023413FA-FD1D-42E4-94FF-CFD398196980

Q35191054-02524023-9B24-444C-AF9A-A3CD916BB318

Q35191054-032E8F85-B2C3-40A5-80E6-A924D2677BF8

Q35191054-1BFA277D-FCE8-4C27-9541-618956AD2A67

Q35191054-22264E40-6EED-452F-8639-39FE9F55A4FA

Q35191054-232294F5-3789-4905-8457-295D10B901CF

Q35191054-2777BF40-5A3A-4B0C-8067-15D596A5C3A4

Q35191054-30E47FFF-8DF1-4A17-BBC0-87B322E7D976

Q35191054-3A52FDA6-E182-4713-A1B9-BF2277CADE0A

Q35191054-60FB504E-150C-4CCF-BE7A-9604BA9CC5A2

P304

Q35191054-34E3ABB0-F44B-46B8-92DA-9BC33CEA5FC0

P31

Q35191054-B6FA0098-31C6-46E9-BDE7-EC80D19AC829

P356

Q35191054-B35EF61C-0177-405A-9336-41763CF1E208

P407

Q35191054-89F6DBB0-2D91-4B19-8C23-8B2B78479982

P433

Q35191054-F4131151-BB3D-41F1-8677-08A3AD030354

P478

Q35191054-EC2EA709-4ED8-47F8-941D-B40309BE6D55

P577

Q35191054-343ABBB3-B0F0-4AED-8E1C-8A88596C1EA7

P698

Q35191054-F38A100A-FBC0-43AB-B39D-5CCAA34904F6

P921

Q35191054-C31B4F8A-FE23-49FA-9916-6D275DFB9880

P932

Q35191054-2392557B-D522-4C45-B963-255AA750C164

P356

P1433

Journal of Clinical Investigation

P1476

Rosiglitazone promotes develop ...... circulating progenitor cells.

@en

P2093

Dwight J Klemm

http://www.w3.org/2001/XMLSchema#string

Joseph T Crossno

http://www.w3.org/2001/XMLSchema#string

Ronald G Gill

http://www.w3.org/2001/XMLSchema#string

Susan M Majka

http://www.w3.org/2001/XMLSchema#string

Todd Grazia

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity is associated with macrophage accumulation in adipose tissue

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.

Effect of thiazolidinediones on body weight in patients with diabetes mellitus.

Resistin and obesity-associated insulin resistance.

Cellular and molecular aspects of adipose tissue development.

Growth and development of adipose tissue.

Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.

Enhancement of adipocyte differentiation by an insulin-sensitizing agent.

P304

3220-3228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI28510

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17143331

http://www.w3.org/2001/XMLSchema#string

P921

P932

1679707

http://www.w3.org/2001/XMLSchema#string